Back

The Role of Pain Frequency in the Divergent Associations Between Cannabis Use and Default Mode Network Connectivity

Brown, T.; Liu, C.; Kroon, E.; Cousijn, J.; Filbey, F.

2026-03-11 pharmacology and therapeutics
10.64898/2026.03.10.26348038 medRxiv
Show abstract

BackgroundChronic pain is one of the most common reasons for medicinal cannabis use, yet the neural mechanisms underlying cannabis-related modulation of pain remain poorly understood. Both pain and cannabis use independently alter functional connectivity within the brains default mode network (DMN) that modulate interoception and self-referential aspects of pain processing. The goal of this study was to examine the interaction between pain and cannabis use on DMN connectivity. MethodsWe measured DMN resting state fMRI functional connectivity (rsFC), past year pain frequency, and cannabis use measures (i.e., grams per day, days a week, years of regular use) from 119 adults who use cannabis near-daily (68 men; Mage= 22.66, SE= .31). Generalized linear models were used to test the main effects and interactions of pain frequency and cannabis use variables. ResultsResults indicated significant interactions between pain and cannabis use where more frequent pain was (1) negatively associated with weekly use or years of use in l-IPL-PCC and r-IPL-PCC rsFC, (2) whereas it was positively associated with daily grams of cannabis in l-IPL-r-IPL rsFC and r-IPL-PCC rsFC (BH-FDR-corrected p< .05). ConclusionsFirst, these findings demonstrate that pain frequency is a key context shaping the neurobiological correlates of exposure to cannabis. Second, divergent interaction effects suggest that, in the context of more frequent pain, cannabis use may relate to rsFC through distinct neural processes that depend on cumulative vs. proximal effects.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
NeuroImage: Clinical
132 papers in training set
Top 0.3%
12.4%
2
Brain, Behavior, and Immunity
105 papers in training set
Top 0.2%
9.2%
3
European Neuropsychopharmacology
15 papers in training set
Top 0.1%
6.9%
4
Psychological Medicine
74 papers in training set
Top 0.3%
6.4%
5
Frontiers in Psychiatry
83 papers in training set
Top 0.8%
4.4%
6
PeerJ
261 papers in training set
Top 1%
4.3%
7
Neuropsychopharmacology
134 papers in training set
Top 0.7%
4.0%
8
Nicotine and Tobacco Research
13 papers in training set
Top 0.1%
3.7%
50% of probability mass above
9
Addiction Biology
47 papers in training set
Top 0.4%
3.1%
10
NeuroImage
813 papers in training set
Top 3%
3.1%
11
Frontiers in Pharmacology
100 papers in training set
Top 1%
2.6%
12
PLOS ONE
4510 papers in training set
Top 45%
2.6%
13
Scientific Reports
3102 papers in training set
Top 45%
2.6%
14
Pain
70 papers in training set
Top 0.5%
2.1%
15
eLife
5422 papers in training set
Top 35%
2.1%
16
Journal of Affective Disorders
81 papers in training set
Top 0.9%
1.8%
17
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.3%
1.8%
18
Brain Sciences
52 papers in training set
Top 0.6%
1.8%
19
Drug and Alcohol Dependence
37 papers in training set
Top 0.4%
1.7%
20
Progress in Neurobiology
41 papers in training set
Top 1%
1.0%
21
Journal of Psychopharmacology
14 papers in training set
Top 0.4%
1.0%
22
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 1%
0.9%
23
Neurotherapeutics
11 papers in training set
Top 0.4%
0.8%
24
Frontiers in Human Neuroscience
67 papers in training set
Top 2%
0.8%
25
Brain Research
35 papers in training set
Top 2%
0.8%
26
JAMA Network Open
127 papers in training set
Top 4%
0.8%
27
Molecular Psychiatry
242 papers in training set
Top 4%
0.7%
28
ACS Pharmacology & Translational Science
40 papers in training set
Top 1%
0.7%
29
International Journal of Environmental Research and Public Health
124 papers in training set
Top 8%
0.6%
30
Psychopharmacology
59 papers in training set
Top 0.7%
0.6%